References

  1. Redondo P, Solano T, Bauza A, Lloret P. Amelanotic melanoma presenting as a scar. Arch Intern Med. 2001; 161(15):1912-3. PubMed | Google Scholar

  2. Spanknebel K, Kaufman HL. Surgical treatment of stage IV melanoma. Clin Dermatol. 2004; 22(3):240-50. PubMed | Google Scholar

  3. Hutchinson J. Melanosis often not black; melanotic whitlow. Br Med J. 1886; 1:491. PubMed | Google Scholar

  4. Grob JJ, Richard MA. Epidemiology and prevention of melanoma. Rev Prat. 2004; 54(11):1181-6. PubMed | Google Scholar

  5. Grange F. Epidemiology of cutaneous melanoma: descriptive data in France and Europe. Ann Dermatol Venereol. 2005;132 (12 Pt 1):975-82. PubMed | Google Scholar

  6. Parker SG, Diffey BL. The transmission of optical radiation through human nails. Br J Dermatol. 1983; 108(1): 11-1. PubMed | Google Scholar

  7. Marcelo H, Grunwald JY, Ronen G, Oren L, Howard JZ. Subungual amelanotic melanoma. Cutis. 2000; 65(5):303-4. PubMed | Google Scholar

  8. Banfield CC, Redburn JC, Dawber RP. The incidence and prognosis of nail apparatus melanoma: a retrospective study of 105 patients in four English regions. Br J Dermatol. 1998; 139(2):276-279. PubMed | Google Scholar

  9. Mohrle M, Hafner HM. Is subungual melanoma related to trauma? Dermatology. 2002; 204(4):259-261. PubMed | Google Scholar

  10. Pizzichetta MA, Talamini R, Stanganelli I, Puddu P, Bono R, Argenziano G. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features. Br J Dermatol. 2004; 150:1117-24. PubMed | Google Scholar

  11. Argenziano G, Zalaudek I, Corona R et al. Vascular structures in skin tumors : a dermoscopy study. Arch Dermatol. 2004; 140(12):1485-9. PubMed | Google Scholar

  12. O?Leary JA, Berend KR, Johnson JL, Levin LS, Seigler HF. Subungual melanoma: a review of 93 cases with identification of prognostic variables. Clin Orthop Relat Res. 2000; 378:206-. PubMed | Google Scholar

  13. Negrier S, Fervers B, Bailly C, Beckendorf V, Cupissol D, Dore JF. Standards, Options and Recommendations (SOR): clinical practice guidelines for diagnosis, treatment and followup of cutaneous melanoma: Fédération Nationale des Centres de Lutte Contre le Cancer. Bull Cancer. 2000;87(2):173-82. PubMed | Google Scholar

  14. Negrier S, Saiag P, Guillot B, Verola O, Avril MF, Bailly C. Guidelines for clinical practice: Standards, Options and Recommendations 2005 for the management of adult patients exhibiting an MO cutaneous melanoma, full report. Ann Dermatol Venereol. 2005; 132(12 Pt 2):10S3-10S85. PubMed | Google Scholar

  15. Quinn MJ, Thompson JE, Crotty K, McCarthy WH, Coates AS. Subungual melanoma of the hand. J Hand Surg [Am]. 1996;21(3):506-511. PubMed | Google Scholar

  16. Brown CD, Zitelli JA. The prognosis and treatment of true local cutaneous recurrent malignant melanoma. Dermatol Surg. 1995; 21(4):285-90. PubMed | Google Scholar

  17. Muir C, Clerc F, Dore JF. Soleil et mélanome. Paris: édition INSERM. 1990; 186 pages. Google Scholar

  18. Essner R, Lee JH, Wanek LA, Itakura H, Morton DL. Contemporary surgical treatment of advanced-stage melanoma. Arch Surg. 2004;139(9):961-6 (discussion 966-7). PubMed | Google Scholar

  19. Olsen G. Some views on the treatment of melanomas of the skin. Arch Chir Neerl. 1970;22(2):79-90. PubMed | Google Scholar

  20. Grunhagen DJ, de Wilt JH, van Geel AN, Eggermont AM. Isolated limb perfusion for melanoma patients-a review of its indications and the role of tumour necrosis factor-alpha. Eur J Surg Oncol. 2006 May;32(4):371-80. PubMed | Google Scholar